We have shown that a drug-resistant mutant from a clinical isolate of herpes simplex virus contains a single point mutation in the DNA polymerase gene that confers resistance to both acyclovir and foscarnet. The mutated amino acid is located within a distinct conserved region shared among of-like DNA polymerases which we designate region VII. We infer that these conserved sequences are directly or indirectly involved in the recognition and binding of nucleotide and PP1 substrates.
Herpes simplex virus (HSV) DNA polymerase (Pol) is both an important target for antiviral therapy and an excellent model for the a-like DNA polymerases (reviewed in reference 6). HSV DNA Pol contains several regions, designated I through VI, conserved among a-like DNA polymerases (20) . Sequence analysis of several HSVpol mutants revealed that mutations that confer resistance to antiviral drugs that mimic and/or compete with deoxynucleoside triphosphate (dNTP) or PPi are distributed within regions I, II, III, and V and in region A, which is shared by only certain a-like DNA polymerases (Fig. 1B) (Fig. 1A) . Two of the subfragments were similar in size (1.1 kbp) and extended from the RpnI site of the pUC19 vector to the second KpnI site within the 3.3-kbppol DNA insert and were isolated together from an agarose gel. The third fragment (3.7 kbp) included the remaining sequences of the pol insert, extending from the second Kpnl site, and also included sequences of the cloning vector (Fig. 1A) . This 3.7-kbp KpnI fragment transferred PFA resistance to infectious KOS DNA at a frequency (0.12%) substantially higher * Corresponding author.
than that obtained when no fragment (0.0047%) or the 1.1-kbp KpnI fragments (0.002%) were added.
PFA-resistant recombinant virus (615.8 P'K1) from the marker transfer experiment using the 3.7-kbp KpnI fragment was then plaque purified and tested for sensitivity to ACV. Both the original resistant isolate, 615.8, and the recombinant virus, 615.8 PrK1, were similarly resistant to ACV with a 50% effective dose of 40 ,uM, while KOS exhibited a 50% effective dose of 6 ,uM (Fig. 2) (20) . However, amino acid 941 is part of a motif recognized by several investigators and termed variously region 4, 9, or IX (3, 13, 18) . This motif is illustrated in Fig. 1B and contains a highly conserved sequence, Lys-Lys-X-Tyr, with the second Lys and the Tyr conserved in all of the polymerases examined. Remarkably, it is this Tyr that is altered in 615. 8 conserved among all of these DNA polymerases except (14) . On the other hand, secondarystructure predictions by others (13) noted a structure transition from a-helical to ,B-sheet at the third amino acid of the motif (Lys-940 in HSV Pol). This transition is shifted to amino acid 941 (His) in the 615.8 Pol, on the basis of the protein secondary-structure analysis of Garnier et al. (9) . Therefore, it is possible that the Tyr-to-His change could alter the secondary structure of this region of Pol to alter recognition and binding of drugs. Determination of the structural consequences of the Tyr-to-His change will, however, require further biophysical and biochemical studies of a-like DNA polymerases.
We thank T. Wang for helpful discussions and blessing in designating the Lys-Lys-X-Tyr motif as region VII.
This work was supported by NIH grants A119838 and RR05381.
